News Industry News Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience May 16, 2017
News Daily News Another Observational CTO Study Confirms Procedural Success of PCI but Doesn't Definitively Show Effect on Outcomes Yael L. Maxwell May 05, 2017
News Conference News EAS 2017 Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive Yael L. Maxwell May 01, 2017
News Daily News Debate Continues Over How Best to Prevent Stroke in Patients With Carotid Stenosis Todd Neale May 01, 2017
News Conference News EAS 2017 FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data Yael L. Maxwell April 26, 2017
News Industry News NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation April 26, 2017
News Daily News Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting L.A. McKeown April 19, 2017
News Daily News PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD Shelley Wood April 12, 2017
News Daily News SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation Yael L. Maxwell April 04, 2017
News Daily News Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes Todd Neale April 03, 2017
News Features Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table? Caitlin E. Cox March 31, 2017
News Daily News Boston Scientific Adds Two More TAVR Valves With Symetis Purchase Michael O'Riordan March 30, 2017
News Conference News ACC 2017 MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns L.A. McKeown March 27, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis Shelley Wood March 06, 2017
News Daily News For Carotid Disease Patients, How Physicians Are Paid Affects the Odds of Revascularization Caitlin E. Cox March 02, 2017